Medifast, Inc.
MED
$12.92
-$0.205-1.56%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 115.73M | 119.00M | 140.16M | 168.56M | 174.74M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 115.73M | 119.00M | 140.16M | 168.56M | 174.74M |
| Cost of Revenue | 31.48M | 30.78M | 34.49M | 45.12M | 47.45M |
| Gross Profit | 84.25M | 88.22M | 105.67M | 123.44M | 127.29M |
| SG&A Expenses | 84.51M | 86.21M | 102.47M | 130.21M | 118.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 116.99M | 118.29M | 138.06M | 176.43M | 166.80M |
| Operating Income | -1.26M | 709.00K | 2.11M | -7.88M | 7.94M |
| Income Before Tax | 526.00K | 1.28M | 1.58M | -10.65M | 11.59M |
| Income Tax Expenses | 1.30M | 474.00K | 449.00K | -2.50M | 3.27M |
| Earnings from Continuing Operations | -772.00K | 801.00K | 1.13M | -8.15M | 8.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -772.00K | 801.00K | 1.13M | -8.15M | 8.32M |
| EBIT | -1.26M | 709.00K | 2.11M | -7.88M | 7.94M |
| EBITDA | 2.02M | 13.08M | 2.22M | -4.81M | 11.20M |
| EPS Basic | -0.07 | 0.07 | 0.10 | -0.75 | 0.76 |
| Normalized Basic EPS | 0.03 | 0.07 | 0.09 | -0.61 | 0.66 |
| EPS Diluted | -0.07 | 0.07 | 0.10 | -0.75 | 0.76 |
| Normalized Diluted EPS | 0.03 | 0.07 | 0.09 | -0.61 | 0.66 |
| Average Basic Shares Outstanding | 10.95M | 10.94M | 10.94M | 10.94M | 10.91M |
| Average Diluted Shares Outstanding | 10.95M | 10.98M | 10.97M | 10.94M | 10.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -25.13% | 0.00% | 0.09% | -0.05% | 8.54% |